logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Return

Evolving guidelines on lipoprotein(a)

delete2025-10-22
delete0
PRE
AI
M
Michael B. Boffa
M
Marlys L. Koschinsky
R
Robert A. Hegele
DOI：10.1097/MOL.0000000000001016delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Elevated plasma lipoprotein(a) [Lp(a)] is a causal and independent risk factor for atherosclerotic cardiovascular disease and an emerging therapeutic target. Over the past 15 years, many medical bodies from around the world have released scientific statements and clinical guidelines regarding Lp(a). This review tracks how recommendations on Lp(a) have evolved over this timeframe.
Keywords:
atherosclerotic cardiovascular disease
clinical guidelines
lipoprotein(a)
preventive cardiology

Journal

Current Opinion in Lipidology cover
Current Opinion in Lipidology
IF:
4.6
Papers:
2.3K
Citations:
3.9K

Organization

No organization information available